Cargando…

Exploration of Pyrido[3,4-d]pyrimidines as Antagonists of the Human Chemokine Receptor CXCR2

Upregulated CXCR2 signalling is found in numerous inflammatory, autoimmune and neurodegenerative diseases, as well as in cancer. Consequently, CXCR2 antagonism is a promising therapeutic strategy for treatment of these disorders. We previously identified, via scaffold hopping, a pyrido[3,4-d]pyrimid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Van Hoof, Max, Claes, Sandra, Boon, Katrijn, Van Loy, Tom, Schols, Dominique, Dehaen, Wim, De Jonghe, Steven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004157/ https://www.ncbi.nlm.nih.gov/pubmed/36903345 http://dx.doi.org/10.3390/molecules28052099

Ejemplares similares

Synthesis and Anti-HIV Activity of a Novel Series of Isoquinoline-Based CXCR4 Antagonists
por: Shad, Mastaneh Safarnejad, et al.
Publicado: (2021)

Signaling properties of the human chemokine receptors CXCR4 and CXCR7 by cellular electric impedance measurements
por: Doijen, Jordi, et al.
Publicado: (2017)

CXCR7/ACKR3-targeting ligands interfere with X7 HIV-1 and HIV-2 entry and replication in human host cells
por: D'huys, Thomas, et al.
Publicado: (2018)

Cellular Electrical Impedance as a Method to Decipher CCR7 Signalling and Biased Agonism
por: Vanalken, Nathan, et al.
Publicado: (2022)

REGA-SIGN: Development of a Novel Set of NanoBRET-Based G Protein Biosensors
por: Boon, Katrijn, et al.
Publicado: (2023)

Studies of Interaction Mechanism between Pyrido [3,4-d] Pyrimidine Inhibitors and Mps1
por: Xing, Cheng, et al.
Publicado: (2021)

Design and Synthesis of a Series of Pyrido[2,3-d]pyrimidine Derivatives as CCR4 Antagonists
por: Gong, Hongwei, et al.
Publicado: (2012)

Comparison of cell-based assays for the identification and evaluation of competitive CXCR4 inhibitors
por: Van Hout, Anneleen, et al.
Publicado: (2017)

Inhibition of T-tropic HIV Strains by Selective Antagonization of the Chemokine Receptor CXCR4
por: Schols, Dominique, et al.
Publicado: (1997)

Stimulation of the atypical chemokine receptor 3 (ACKR3) by a small-molecule agonist attenuates fibrosis in a preclinical liver but not lung injury model
por: Van Loy, Tom, et al.
Publicado: (2022)

A Set of Experimentally Validated Decoys for the Human CC Chemokine Receptor 7 (CCR7) Obtained by Virtual Screening
por: Proj, Matic, et al.
Publicado: (2022)

Development of a Novel SPR Assay to Study CXCR4–Ligand Interactions
por: Boonen, Arnaud, et al.
Publicado: (2020)

The Three-Component Synthesis of 4-Sulfonyl-1,2,3-triazoles via a Sequential Aerobic Copper-Catalyzed Sulfonylation and Dimroth Cyclization
por: Van Hoof, Max, et al.
Publicado: (2021)

D-Peptide-Based Probe for CXCR4-Targeted Molecular Imaging and Radionuclide Therapy
por: Luyten, Kaat, et al.
Publicado: (2021)

Pyrido[3,4-d]pyrimidin-4(3H)-one metabolism mediated by aldehyde oxidase is blocked by C2-substitution
por: Hayes, Angela, et al.
Publicado: (2016)

Fluorescent CXCR4 chemokine receptor antagonists: metal activated binding
por: Khan, Abid, et al.
Publicado: (2007)

Medicinal chemistry perspective of pyrido[2,3-d]pyrimidines as anticancer agents
por: Kumar, Adarsh, et al.
Publicado: (2023)

Pyrido-Fused Deazapurine Bases: Synthesis and Glycosylation of 4-Substituted 9H-Pyrido[2′,3′:4,5]- and Pyrido[4′,3′:4,5]pyrrolo[2,3-d]pyrimidines
por: Veselovská, Lucia, et al.
Publicado: (2020)

Exploratory Studies on Development of the Chemokine Receptor CXCR4 Antagonists Toward Downsizing
por: Tamamura, Hirokazu, et al.
Publicado: (2008)

Chemokine receptor CXCR4 oligomerization is disrupted selectively by the antagonist ligand IT1t
por: Ward, Richard J., et al.
Publicado: (2020)

Review on the Synthesis and Therapeutic Potential of Pyrido[2,3-d], [3,2-d], [3,4-d] and [4,3-d]pyrimidine Derivatives
por: Campos, Joana F., et al.
Publicado: (2022)

From Quinoxaline, Pyrido[2,3-b]pyrazine and Pyrido[3,4-b]pyrazine to Pyrazino-Fused Carbazoles and Carbolines
por: Lassagne, Frédéric, et al.
Publicado: (2018)

Dataset of (±)-NBI-74330 (CXCR3 antagonist) influence on chemokines under neuropathic pain
por: Piotrowska, Anna, et al.
Publicado: (2018)

Pyrido[2,3-d]pyrimidin-7(8H)-ones: Synthesis and Biomedical Applications
por: Jubete, Guillem, et al.
Publicado: (2019)

Electro-Oxidative C3-Selenylation of Pyrido[1,2-a]pyrimidin-4-ones
por: Shi, Jianwei, et al.
Publicado: (2023)

Therapeutic Perspectives of HIV-Associated Chemokine Receptor (CCR5 and CXCR4) Antagonists in Carcinomas
por: González-Arriagada, Wilfredo Alejandro, et al.
Publicado: (2022)

6-(2,6-Dimethylphenyl)pyrido[2,3-d]pyrimidin-7-amine
por: Nukui, Seiji, et al.
Publicado: (2009)

Establishment of a novel CCR5 and CXCR4 expressing CD4(+ )cell line which is highly sensitive to HIV and suitable for high-throughput evaluation of CCR5 and CXCR4 antagonists
por: Princen, Katrien, et al.
Publicado: (2004)

Control of cell migration in the development of the posterior lateral line: antagonistic interactions between the chemokine receptors CXCR4 and CXCR7/RDC1
por: Dambly-Chaudière, Christine, et al.
Publicado: (2007)

Synthesis, Herbicidal Activity, Mode of Action, and In Silico Analysis of Novel Pyrido[2,3-d]pyrimidine Compounds
por: Min, Lijing, et al.
Publicado: (2023)

Identification of Anti-Malarial Compounds as Novel Antagonists to Chemokine Receptor CXCR4 in Pancreatic Cancer Cells
por: Kim, Joseph, et al.
Publicado: (2012)

Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore‐based virtual screening approach
por: Mirza, Muhammad Usman, et al.
Publicado: (2020)

Agonists for the Chemokine Receptor CXCR4
por: Lefrançois, Marilou, et al.
Publicado: (2011)

Specific Receptors for the Chemokines CXCR2 and CXCR4 in Pancreatic Cancer
por: Litman-Zawadzka, Ala, et al.
Publicado: (2020)

3-(2-Chloroethyl)-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
por: Jasinski, Jerry P., et al.
Publicado: (2009)

Anticancer evaluation and molecular modeling of multi-targeted kinase inhibitors based pyrido[2,3-d]pyrimidine scaffold
por: Elzahabi, Heba S. A., et al.
Publicado: (2018)

Triethylammonium Hydrogen Sulfate [Et(3)NH][HSO(4)]-Catalyzed Rapid and Efficient Multicomponent Synthesis of Pyrido[2,3-d]pyrimidine and Pyrazolo[3,4-b]pyridine Hybrids
por: Jadhav, Chetan, et al.
Publicado: (2021)

Differences in Sulfotyrosine Binding amongst CXCR1 and CXCR2 Chemokine Ligands
por: Moussouras, Natasha A., et al.
Publicado: (2017)

The Role of the CXCL12/CXCR4/CXCR7 Chemokine Axis in Cancer
por: Shi, Yi, et al.
Publicado: (2020)

Spiro[cyclopentane-1,2′(1′H)-pyrido[2,3-d]pyrimidin]-4′(3′H)-one
por: Shi, Daxin, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_0acr31e58k8q9t1n5kt215hir1